Filter
1132
Filtered Results: 1132
Text search:
pharmaceutical
manufacturers
Featured
Recommendations
108
New Publications
284
Language
Document type
No document type
520
Studies & Reports
234
Guidelines
192
Manuals
79
Strategic & Response Plan
59
Fact sheets
20
Training Material
14
Situation Updates
8
Resource Platforms
3
Brochures
2
Infographics
1
Countries / Regions
Global
52
India
44
Kenya
40
Western and Central Europe
31
Ethiopia
30
Nigeria
25
South Africa
18
Ghana
17
Sierra Leone
15
Uganda
15
Ukraine
14
Zimbabwe
14
Bangladesh
14
Nepal
13
Malawi
13
Philippines
13
Rwanda
12
Tanzania
12
Eastern Europe
12
Zambia
12
Africa
11
Latin America and the Carribbean
11
South–East Asia Region
10
Namibia
10
Eastern Europe and Central Asia
8
Eswatini/ Swaziland
8
Syria
7
Indonesia
7
Liberia
7
Myanmar / Burma
7
West and Central Africa
6
Botswana
6
Thailand
5
East and Southern Africa
5
Senegal
4
Cambodia
4
Burkina Faso
3
USA
3
Haiti
3
Asia
3
Middle East and North Africa
3
Western Pacific Region
3
Egypt
3
North Macedonia
2
Serbia
2
Lesotho
2
Benin
2
Cameroon
2
Albania
2
Laos
2
Kyrgyzstan
2
Jordan
2
Germany
2
Congo, Democratic Republic of
2
North America
2
Jamaica
2
United Kingdom
2
Lebanon
2
Vietnam
2
Russia
2
Sudan
2
Tajikistan
1
Timor Leste/ East Timor
1
Australia
1
China
1
Kazakhstan
1
Chile
1
Iran
1
Fiji
1
Uzbekistan
1
Afghanistan
1
Mongolia
1
Bulgaria
1
Guinea
1
Mozambique
1
Armenia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Maldives
1
Papua New Guinea
1
Moldova
1
Georgia
1
Mali
1
Libya
1
South Sudan
1
Iraq
1
Somalia
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
383
Clinical Guidelines
107
Public Health
69
Key Resources
44
Women & Child Health
39
Pharmacy & Technologies
35
Capacity Building
9
Toolboxes
AMR
136
Pharmacy
133
COVID-19
81
TB
57
Mental Health
56
HIV
52
Rapid Response
48
Planetary Health
27
Caregiver
26
Global Health Education
25
NTDs
22
NCDs
22
Conflict
22
Health Financing Toolbox
16
Specific Hazards
12
Ebola
10
Polio
8
Refugee
7
Disability
7
Natural Hazards
4
Zika
2
Cholera
1
Social Ethics
1
2016-2018 Early implementation,
This report presents 2015 data on the consumption of systemic antibiotics from 65 countries and areas, contributing to our understanding of how antibiotics are used in these countries. In addition, the report documents early efforts of the World Health Organization (...
The purpose of the landscape analysis is ultimately to facilitate improved engagement of private providers, thereby contributing to universal access to quality and affordable TB care and the end of the TB epidemic. It focuses on the role of private for-profit providers and on specific challenges and...
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided i...
One health Response to AMR Containment.
In a significant move for the public health sector, Kerala has become the first state in India to launch an action plan to combat the growing cases of antimicrobial immunity, arising primarily from irrational use of medicines and excessive antibiotics used in...
This report presents an overview of the transition process in Azerbaijan, some sustainability aspects and challenges stemming from donor withdrawal from TB-related activities, along with recommendations on how to overcome transition-related difficulties and ensure sustainability.
Version 1.1. The WHO protocol has been adapted to resource-limited settings and builds on existing methodologies from the European Centre for Disease Prevention and Control (ECDC), the Global PPS project from University of Antwerp, the US Centers for Disease Control and Prevention (CDC), and the Med...
Social Determinants of Health Discussion Paper 1 (Debates). This paper was prepared for the launch of the Commission on Social Determinants of Health (CSDH) by its secretariat based at WHO in Geneva. It was discussed by the Commissioners and then revised considering their input.
Version 1.1
Department of Mental Health and Substance Abuse
This paper focuses on the Sustainable Development Goals related to poverty, economic growth, inequality, health, food production and the environment. It presents concrete examples of the underlying and complex aspects of antibiotic resistance and its impacts across different Sustainable Development ...
This compendium collates current tools and resources on quality improvement developed by the WHO Service Delivery and Safety Department and provides examples of how the tools and resources have been applied in country settings. The target audience for this document are ministries of health, facility...
WHO Western Pacific Regional Strategy to Reduce Alcohol-Related Harm
WORLD DRUG REPORT 2017
World Drug Report 2017
-1-
Accessed: 14.03.2019
Building laboratory testing capacity
The WHO Regional Office for Europe, the WHO Collaborating Centre on Culture and Health at the University of Exeter (United Kingdom) and the National Institute of Mental Health (Czechia) convened a workshop on culture and reform of mental health care in central and eastern Europe on 2–3 October 201...
World Drug Report 2018
-3-
In the last quarter century, several projects emerged to reform mental health services in Latin American and Caribbean countries. Some did not survive the difficulties that inevitably arise in processes of change, and ended up disappearing before the intended changes could be introduced. Others, how...
Global concerns: Implications for the future
Child Mental Health Atlas
Universal health coverage ensures everyone has access to the health services they need without suffering financial hardship as a result. In December 2012, a UN resolution was passed encouraging governments to move towards providing universal access to affordable and quality health care services. As ...
